Inhaled steroids with and without regular salmeterol for asthma: serious adverse events

CJ Cates, S Schmidt, M Ferrer, B Sayer… - Cochrane Database …, 2018 - cochranelibrary.com
Background Epidemiological evidence has suggested a link between use of beta₂‐
agonists and increased asthma mortality. Much debate has surrounded possible causal …

Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents …

Y Oba, S Anwer, T Maduke, T Patel… - Cochrane Database of …, 2022 - cochranelibrary.com
Background Current guidelines recommend a higher‐dose inhaled corticosteroids (ICS) or
adding a long‐acting muscarinic antagonist (LAMA) when asthma is not controlled with …

[HTML][HTML] Impact of inhaled fluticasone propionate/salmeterol on health-related quality of life in asthma: A network meta-analysis

K Maneechotesuwan, D Singh, LG Fritscher… - Respiratory …, 2022 - Elsevier
Objective This network meta-analysis (NMA) compared fixed-dose, twice daily fluticasone
propionate/salmeterol (FP/Sal) vs. inhaled corticosteroid (ICS) and other ICS/long-acting …

Maintenance Therapy for Children and Adolescents with Asthma: Guidelines and Recommendations from the Emilia-Romagna Asthma (ERA) Study Group

V Fainardi, C Caffarelli, M Deolmi, G Zambelli… - Journal of Clinical …, 2023 - mdpi.com
Asthma is the most frequent chronic disease of childhood, affecting up to 20% of children
worldwide. The main guidelines on asthma maintenance therapy in pediatrics suggest …

Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick®): A Review in Asthma

J Paik, LJ Scott, RA Pleasants - Clinical Drug Investigation, 2018 - Springer
The novel, easy-to-use, breath-actuated fluticasone propionate/salmeterol multidose dry
powder inhaler (MDPI)(AirDuo RespiClick®) was recently approved in the USA for twice …

Efficacy and safety of Once-Daily Vilanterol/Fluticasone furoate MDI in persistent asthma: Phase 3 OD-INHALE Study

A Kumar, MK Jain, VB Barge, RS Kumar… - Journal of …, 2024 - Taylor & Francis
Introduction Once-daily inhalers have been shown to improve adherence leading to lesser
discontinuation compared to twice-or thrice-daily inhalers in management of asthma …

[HTML][HTML] VOLVER ATRAS

J Pickard - farmacosalud.com
La desnutrición es frecuente en enfermos en lista de espera para un trasplante y constituye
un factor de riesgo de morbilidad postrasplante. Los enfermos en cualquier momento del …

[引用][C] Therapeutic Class Overview

IPIOP Modifying